Targeted proteomics of cerebrospinal fluid in treatment naïve multiple sclerosis patients identifies immune biomarkers of clinical phenotypes.
Rabin A, Bello E, Kumar S, Zeki DA, Afshari K, Deshpande M, Francis N, Khalighinejad F, Umeton R, Radu I, Qutab F, Kwong D, Kurban M, Hemond C, Richmond JM, Ionete C.
Rabin A, et al. Among authors: deshpande m.
Sci Rep. 2024 Sep 18;14(1):21793. doi: 10.1038/s41598-024-67769-1.
Sci Rep. 2024.
PMID: 39294186
Free PMC article.